Phronesis Artificial Intelligence produces pharmaceutical software for autonomous drug design.
Phronesis Artificial Intelligence has raised $300K in total funding. The most recent round was Debt Financing. The last funding was announced in September 2021.
Phronesis Artificial Intelligence is headquartered in Daphne, United States.
Phronesis Artificial Intelligence produces pharmaceutical software for autonomous drug design.
Phronesis Artificial Intelligence is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Phronesis Artificial Intelligence — Funding & Investors." VCBacked, September 8, 2021, https://www.vcbacked.co/company/phronesis-artificial-intelligence. Accessed September 30, 2026.
VCBacked. (2021). Phronesis Artificial Intelligence — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/phronesis-artificial-intelligence
{{cite web |title=Phronesis Artificial Intelligence — Funding & Investors |url=https://www.vcbacked.co/company/phronesis-artificial-intelligence |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated